Eli Lilly's Foundayo and Zepbound Obesity Medications Gain Insurance Coverage
Eli Lilly announced expanded insurance coverage for its obesity medications Foundayo and Zepbound through major pharmacy benefit managers. This will allow millions of Americans to access these FDA-approved treatments at low out-of-pocket costs starting in June.
Tickers: $LLY
Topics: drug_access healthcare obesity_treatment